Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Tuesday 15 November 2016 7:00 am

Evelyn Wallace of AXA advises on respectfully managing an employee with cancer

By: Evelyn Wallace

Add as a preferred source on Google

With an estimated 2.5m people living with cancer in the UK there’s a strong chance that you, or someone you know, has personal experience of the disease.

Perhaps you’ve managed an employee who’s been diagnosed with cancer? With the number of people in the UK affected by cancer set to rise to 4m by 2030, there is every possibility that you may be faced with this situation at some point in your management career. And, if this does occur, it’s important to be prepared so that you can support them practically, sensitively and in the way that works best for them.

Research from AXA PPP healthcare highlights that a fifth (21 per cent) of UK managers with employees who have had cancer have never discussed their illness with them, and 20 per cent are unsure how to even broach the subject of cancer – or, indeed, other illnesses – with employees.

Stigma

Evidently a stigma still surrounds cancer so to help reduce awkwardness and help you offer the right support to an employee it’s important to be proactive. If they’ve been away receiving treatment, then catching up with them before they return to work will help you understand whether, or how, they want to talk about their cancer. So agree a good time and place to talk and let them set the pace of the conversation. Ask yourself whether they’re making light of their situation as a coping mechanism. Or, are they having difficulty talking about it?

Ask whether they would like their team to know how they’re getting on – an offer to disclose such news on their behalf may be appreciated. This could include colleagues with whom they are close, or whose workload may be affected by any time they have off during the course of their treatment.

Our research reveals that 17 per cent of managers who had an employee with cancer return to work admitted having told the employee’s colleagues about their cancer, without discussing it with the employee, because they thought their colleagues should know about it.

But do remember that an employee may wish to be in control and tell colleagues personally, so ask how much they wish to share. It could be that work offers them a sense of normality which helps them cope, so you must respect any request for confidentiality.

Adjustments

You may need to consider workplace adjustments – such as a phased return to normal duties – and alter your management style when the employee returns. Nearly two-thirds of managers we surveyed who had an employee return to work after cancer said they didn’t change their approach. Instead, it’s integral to discuss their preferred way of moving forward.

Respect that your employee may need time off for appointments, treatment and recovery, so outline organisational policies on flexible working. Explain arrangements regarding paid, unpaid and compassionate leave. Perhaps your organisation has an employee assistance programme that offers counselling.

Enlisting a colleague to handle work and forwarding any important emails in their absence will also help. Fundamentally, facilitate a smooth transition to and from work, so that it does not feel like upheaval to your employee, or put unnecessary strain on them.

Appreciate that not every day is the same for someone with, or recovering from, any serious illness and that their mental and physical health may vary. The first step towards managing cancer in the workplace effectively is to break down the stigma and communicate openly, with understanding and support.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Personal Development

Trending Articles

  • Ocado boss Steiner ‘energised about future’ despite succession battle

  • Foxtons shares tumble as estate agent takes £3m knock from Renters’ Rights Act

  • Engineering group picked off London Stock Exchange in £4.1bn deal

  • CoStar Data Shows Amazon, Defence and Chinese Firms Drive UK Warehouse Demand Recovery

  • How to cut the cost of your holiday this summer with Complete Savings

More from City PM

  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • People named Mark called upon to raise money at London charity golf day

    Sport Business
    Breaking news concept with digital globe and newspaper headlines on a blue background, representing global journalism.
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

    Business Wire
  • Allianz tech blitz dethrones AXA to claim Europe’s insurance AI crown

    Insurance
    Allianz is set to cut 650 jobs in the UK.

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook